(2026). From imaging heterogeneity to clinical decision: A novel imaging biomarker based on bone marrow kinetics for advanced NSCLC patients in partial response. EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"From Imaging Heterogeneity to Clinical Decision: A Novel Imaging Biomarker Based on Bone Marrow Kinetics for Advanced NSCLC Patients in Partial Response."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"From Imaging Heterogeneity to Clinical Decision: A Novel Imaging Biomarker Based on Bone Marrow Kinetics for Advanced NSCLC Patients in Partial Response."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.